Finance

Lists
1OT:FRA
Ovid Therapeutics Inc
2,12 €
-1,85%
(-0,040) 1D
13 հոկ, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1OT...
Open
2,12 €
High
2,12 €
Low
2,12 €
Mkt. cap
427,70 մլն
Avg. vol.
2,00
Volume
0,00
52-wk high
2,52 €
52-wk low
0,97 €
No. of employees
23
Open
2,12 €
High
2,12 €
Low
2,12 €
Mkt. cap
427,70 մլն
Avg. vol.
2,00
Volume
0,00
52-wk high
2,52 €
52-wk low
0,97 €
No. of employees
23
News stories
From web sources and news partners
About Ovid Therapeutics Inc
CEO-
Employees23
Founded2014
Headquarters-
Sector-
Websiteovidrx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
132,00 հզր
718,00 հզր
-
733,00 հզր
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5,87 մլն
6,59 մլն
11,18 մլն
9,96 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,78 մլն
6,42 մլն
6,66 մլն
6,17 մլն
Operating expense
12,66 մլն
13,01 մլն
17,85 մլն
16,13 մլն
Total operating expenses
12,66 մլն
13,01 մլն
17,85 մլն
16,13 մլն
Operating income
-12,52 մլն
-12,29 մլն
-17,85 մլն
-15,40 մլն
Other non operating income
62,00 հզր
57,00 հզր
121,00 հզր
-869,00 հզր
EBT including unusual items
-12,16 մլն
9,66 մլն
-16,99 մլն
-15,01 մլն
EBT excluding unusual items
-12,16 մլն
-11,39 մլն
-16,99 մլն
-14,71 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12,16 մլն
9,66 մլն
-16,99 մլն
-15,01 մլն
Net profit margin
-9 210,61%
1 345,82%
-
-2 047,61%
Earnings per share
-0,17
0,06
-0,12
-0,08
Interest and investment income
303,00 հզր
847,00 հզր
737,00 հզր
1,56 մլն
Interest expense
-
-
-
-
Net interest expenses
303,00 հզր
847,00 հզր
737,00 հզր
1,56 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-12,51 մլն
-12,28 մլն
-17,81 մլն
-15,38 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps